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etastases to the breast from other organs are not common.1 Among
lesions metastatic to the breast, carcinoma of the opposite breast, mul-
ticentric lymphoid malignancies, and disseminated melanoma consti-
tute the most likely sources.2 Thymic carcinoma is a rare malignant
neoplasm representing 0.2% to 1.5% of all malignancies.3 The incidence of distant
metastasis from thymic carcinoma varies from 1.5% to 15.5%, and the tumor metas-
tasizes most frequently to the liver, followed by the kidney and extrathoracic lymph
nodes.4 We present a case of thymic carcinoma metastatic to the breast. To our
knowledge, this is the first report of thymic carcinoma metastatic to the breast.
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Case Report
A 51-year-old woman was referred to the hospital with
1-year history of stiffness of the neck and abnormal find-
ings on chest radiography. Chest radiography showed an
abnormal mass in the mediastinum (Figure 1). Computed
tomography revealed the left anterior mediastinal mass
abutting the ascending aorta, the aortic arch, and the
main pulmonary artery and compressing the left bra-
chiocephalic vein (Figure 2). The patient had a thoracoto-
my with resection of a mediastinal tumor. The histologic
diagnosis was thymic carcinoma, poorly differentiated
squamous cell type with focal involvement of the upper
resection margin (Figure 3). The dissected mediastinal
lymph nodes were free of carcinoma (Masaoka stage III).
Subsequently during the next 5 months, the patient
received adjuvant chemotherapy consisting of dox-
orubicin [40 mg/(m2 ⋅ d)], cisplatin [75 mg/(m2 ⋅ d)],
vincristine [0.6 mg/(m2 ⋅ d)], and cyclophosphamide [700
mg/(m2 ⋅ d)] for 5 cycles and radiation therapy at 5940
cGy to the tumor area in the mediastinum after the third
chemotherapy cycle.
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After the fifth chemotherapy cycle, the patient
had a palpable mass in the right upper breast.
Mammography revealed an oval mass in the
right upper breast (Figure 4). On sonography, an
oval, hypoechoic mass with a nonparallel orien-
tation was depicted in the upper outer portion of
the right breast, corresponding to the area of pal-
pable abnormality (Figure 5). Increased vascular-
ity in the mass was detected with color Doppler
sonography. Sonographically guided 14-gauge
core needle biopsy was performed with 5 passes,
and the histologic diagnosis was metastatic kera-
tinizing squamous thymic carcinoma. Irregularly
sized nests of polygonal cells were embedded in
a densely fibrous stroma, and tumor cells were
poorly differentiated with a small to moderate
amount of eosinophilic cytoplasm, vesicular
nuclei, and prominent nucleoli. Squamous
pearls were found occasionally. The histologic
features were similar to those of the mediastinal
mass, which had been resected 6 months earlier
(Figure 6). The patient was treated with radiation
therapy at 3750 cGy to the tumor area in the right
upper breast and subsequently with combined
chemotherapy of irinotecan and methotrexate.
The metastatic lesion decreased in size by 50%
after 2 cycles, but chemotherapy was discontin-
ued per the patient’s request. Three months later,
another metastatic lesion was discovered in the
right forearm. Nine months later, a metastatic
lesion was detected in the brain, and 1 year later,
a metastatic right pleural lesion was discovered.
The patient subsequently started receiving
chemotherapy again.
Discussion
Thymic carcinoma is a rare malignant neoplasm,
accounting for only 0.06% of thymic neoplasms.
Thymic carcinoma arises from thymic epithelial
cells with overt features of malignancy similar to
those of carcinoma arising in any other organ,
with a propensity for capsular invasion and
metastasis.3,5 Histologically, thymic carcinoma is
differentiated from thymoma by obvious cyto-
logic atypia.6 Thymic carcinoma often metasta-
sizes to the regional lymph nodes and variable
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Figure 1. Posteroanterior chest radiograph shows a large mass
in the left anterior mediastinum (arrows). 
Figure 2. Contrast-enhanced computed tomograms at the level of the aortic arch (A) and the carina (B) show the left anterior medi-
astinal mass with heterogeneous enhancement and necrosis, measuring 5.5 × 5.0 cm, abutting the ascending aorta, the aortic arch,
and the main pulmonary artery, stretching the left brachiocephalic vein, and extending to adjacent mediastinal fat.
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extrathoracic organs, particularly bone, lung,
and liver.7 To our knowledge, metastasis to the
breast has not been reported.
Although primary breast cancer is the most
common malignancy in women in the Western
world,8 metastases to the breast from extramam-
mary malignant neoplasms are rare and report-
edly account for 0.5% to 6.6% of all breast
malignancies.9,10 Approximately 400 patients
with secondary involvement of the breast by
extramammary primary tumors have been
reported to date, and hematologic neoplasms,
malignant melanoma, and lung carcinoma, in
decreasing order of frequency, are the most com-
monly reported primary tumors to metastasize to
the breast.8 Most patients have a known diagnosis
of carcinoma at the time of the appearance of
breast metastases, as in this case. Approximately
one third of patients are known to have systemic
and diffuse metastatic disease before metastasis to
the breast, but breast metastasis may be the first
manifestation of disease in up to 25% of cases.11,12
Hematogenous metastasis to the breast most
commonly consists of single or multiple discrete
nodules that tend to have similar sizes on palpa-
tion and mammography.9 Clinically, breast
metastases occur as palpable, round masses that
may not be easily differentiated from solid,
benign nodules. Breast metastases are firm in
consistency and freely mobile with no fixation to
the skin or the underlying pectoralis muscle.
Because these lesions show rapid growth, an
important clue to their nature may be a rapid
increase in the size of nodules between interval
mammography or sonography.13 The most com-
mon mammographic appearance of breast
metastases is that of 1 or more circumscribed
round nodules with slightly irregular margins,
located in the upper outer quadrants, without
spiculations, calcifications, or other signs of a
surrounding desmoplastic reaction that charac-
terize most primary carcinomas.13,14 A variety of
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Figure 3. Microscopic specimen of the resected mediastinal
mass shows keratinizing squamous thymic carcinoma. Irregularly
sized nests of polygonal cells are embedded in a densely fibrous
stroma with occasional squamous pearls (hematoxylin-eosin,
original magnification ×400).
Figure 4. Bilateral mediolateral oblique (MLO) mammograms
show an oval, hyperdense mass in the right (R) breast (arrow)
with no abnormalities noted in the left (L) breast.
Figure 5. Sonogram of the upper outer portion of the right
breast in the region of the palpable abnormality shows a 10 ×
10 × 10-mm oval, hypoechoic mass with a nonparallel orienta-
tion and an echogenic halo, which was classified as American
College of Radiology Breast Imaging Reporting and Data System
category 4.
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sonographic findings have been reported,
including well-defined or poorly defined, hyper-
echoic or hypoechoic, solid masses with acoustic
shadowing or increased through-transmis-
sion.15,16 Typical metastatic lesions are rounded
or oval, with low echogenicity and a well-defined
posterior wall.12 Vascularity of some lesions can
be visualized with color flow Doppler sonogra-
phy. In this case, the mammographic and sono-
graphic findings of the metastatic breast lesion
were relatively typical, as discussed.
Distinguishing between primary breast adeno-
carcinoma and a metastatic deposit may be
extremely difficult because of the wide spectrum
of presentations of the metastatic nodules.
Metastatic lesions may simulate primary breast
carcinoma or benign abnormalities radiographi-
cally. Accurate diagnosis, differentiating primary
from metastatic breast carcinoma, is important
for rational and optimal therapy and avoidance
of unnecessary mastectomies. Consequently,
metastatic carcinoma must be confirmed by
appropriate histopathologic and immunohisto-
chemical examinations.8
In summary, we describe a case of thymic
carcinoma metastatic to the breast. Metastatic
nodules in the breast are uncommon. When
mammography and sonography show a mass
without the typical features of primary breast
carcinoma in a patient with a known extramam-
mary neoplasm, metastasis to the breast should
be considered and confirmed by appropriate
histopathologic examination.
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Figure 6. Microscopic specimen of the breast mass shows irreg-
ular nests of polygonal tumor cells with densely fibrous stroma,
which are similar to those of the mediastinal mass of keratiniz-
ing squamous thymic carcinoma (hematoxylin-eosin, original
magnification ×400).
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